<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     (Replace this text with the legend)
</LEGEND>
<CIK>                         0000908401
<NAME>                        Glyko Biomedical Ltd.
<MULTIPLIER>                  1
<CURRENCY>                    US Dollars

<S>                             <C>
<PERIOD-TYPE>                 3-Mos
<FISCAL-YEAR-END>             DEC-31-2000
<PERIOD-START>                JUL-01-2000
<PERIOD-END>                  SEP-01-2000
<EXCHANGE-RATE>               1
<CASH>                        722160
<SECURITIES>                  1397217
<RECEIVABLES>                 7407
<ALLOWANCES>                  0
<INVENTORY>                   0
<CURRENT-ASSETS>              2126784
<PP&E>                        0
<DEPRECIATION>                0
<TOTAL-ASSETS>                24117341
<CURRENT-LIABILITIES>         526803
<BONDS>                       0
         0
                   0
<COMMON>                      22535096
<OTHER-SE>                    1055442
<TOTAL-LIABILITY-AND-EQUITY>  24117341
<SALES>                       0
<TOTAL-REVENUES>              17934
<CGS>                         0
<TOTAL-COSTS>                 150500
<OTHER-EXPENSES>              2366036
<LOSS-PROVISION>              0
<INTEREST-EXPENSE>            0
<INCOME-PRETAX>               (2498602)
<INCOME-TAX>                  (2498602)
<INCOME-CONTINUING>           (2498602)
<DISCONTINUED>                0
<EXTRAORDINARY>               0
<CHANGES>                     0
<NET-INCOME>                  (2498602)
<EPS-BASIC>                   (.07)
<EPS-DILUTED>                 (.07)



</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission